A recent study investigated whether an increase in access to PrEP would increase the likelihood of adherence to the medication. Do you think this would work in your practice?
Recently, the USPSTF published recommendations for pre-exposure prophylaxis use in high-risk individuals. But would you prescribe PrEP to women are at risk for HIV exposure as well? Let us know by taking...
